Congenital and Genetic Conditions

May 27, 2020| Posted in: Congenital And Genetic Conditions, Drug Development, Lysosomal Storage Disorders

Protalix’ Fabry Disease Clinical Program

Dror Bashan, President and CEO of Protalix Biotherapeutics…
May 21, 2020| Posted in: Cancers, Congenital And Genetic Conditions, News, Treatment

Data from Von-Hippel-Lindau Clinical Trial Shows Promise for HIF-2a Inhibitor

Eric Jonasch, MD, Professor, Department of Genitourinary Medical…
May 20, 2020| Posted in: Congenital And Genetic Conditions, Metabolic Disorders, Musculoskeletal Diseases

Overview of the Mucopolysaccharidoses

Heather A. Lau, MD, Director, Lysosomal Storage Disease…
May 7, 2020| Posted in: Congenital And Genetic Conditions, Expert Perspectives, Musculoskeletal Diseases

Congenital Myotonic Dystrophy

Michael Snape, PhD, Chief Scientific Officer at AMO…

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

CME Program: Fabry Disease Highlights from WORLDSymposium 2020

Ozlem Goker-Alpan, MD highlights the latest Fabry disease information from the WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with this rare disease.

CME Program: Mucopolysaccharidoses (MPSs) Highlights from WORLDSymposium 2020

Barbara K. Burton, MD highlights the latest information about MPSs from WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with these rare diseases.

Congenital and Genetic Conditions

Topics

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.